EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Deciphering the nuclear bile acid receptor FXR paradigm

Salvatore Modica, Raffaella M Gadaleta, Antonio Moschetta

Nuclear Receptor Signaling · 2010-01 · 8 (1)

DOI: 10.1621/nrs.08005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nuclear Receptor Signaling, online erschienen am 19.11.2010. Verfasst von Salvatore Modica und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Lipid Metabolism and Cancer, Consorzio Mario Negri Sud, Santa Maria Imbaro, Chieti, Italy. Die Arbeit wurde bisher 277-mal zitiert (Crossref) und nennt 208 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Originally called retinoid X receptor interacting protein 14 (RIP14), the farnesoid X receptor (FXR) was renamed after the ability of its rat form to bind supra-physiological concentrations of farnesol. In 1999 FXR was de-orphanized since primary bile acids were identified as natural ligands. Strongly expressed in the liver and intestine, FXR has been shown to be the master transcriptional regulator of several entero-hepatic metabolic pathways with relevance to the pathophysiology of conditions such as cholestasis, fatty liver disease, cholesterol gallstone disease, intestinal inflammation and tumors. Furthermore, given the importance of FXR in the gut-liver axis feedbacks regulating lipid and glucose homeostasis, FXR modulation appears to have great input in diseases such as metabolic syndrome and diabetes. Exciting results from several cellular and animal models have provided the impetus to develop synthetic FXR ligands as novel pharmacological agents. Fourteen years from its discovery, FXR has gone from bench to bedside; a novel nuclear receptor ligand is going into clinical use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsAtherosclerosisBile Acids and SaltsCholestasisDiabetes MellitusGallstonesGastrointestinal Stromal TumorsGene Expression RegulationGlucoseHyperlipidemiasIntestinal DiseasesLiver NeoplasmsLiver RegenerationRatsReceptors, Cytoplasmic and NuclearTranscription FactorsTriglyceridesReceptor, Farnesoid X-Activated

Substanzen

Bile Acids and SaltsGlucoseReceptors, Cytoplasmic and NuclearTranscription FactorsTriglyceridesReceptor, Farnesoid X-Activated

Autor:innen und Institutionen

  • Laboratory of Lipid Metabolism and Cancer, Consorzio Mario Negri Sud, Santa Maria Imbaro, Chieti, Italy.

Zitieren

APA

Modica, S., Gadaleta, R. M., & Moschetta, A. (2010). Deciphering the nuclear bile acid receptor FXR paradigm. Nuclear Receptor Signaling, 8(1). https://doi.org/10.1621/nrs.08005

Vancouver

Modica S, Gadaleta RM, Moschetta A. Deciphering the nuclear bile acid receptor FXR paradigm. Nuclear Receptor Signaling. 2010;8(1). doi:10.1621/nrs.08005

BibTeX
@article{Modica2010,
  author = {Modica, Salvatore and Gadaleta, Raffaella M and Moschetta, Antonio},
  title = {Deciphering the nuclear bile acid receptor FXR paradigm},
  journal = {Nuclear Receptor Signaling},
  year = {2010},
  volume = {8},
  number = {1},
  doi = {10.1621/nrs.08005}
}
Kostenlos starten →